What is Precigen Inc (PGEN) stock price today?

Precigen Inc (PGEN) currently trades at $4.16 per share. The stock has a market capitalization of $1.46B and a P/E ratio of —x.

Is PGEN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Precigen Inc has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 4/9 and Altman Z-Score is -21.62.

What is Precigen Inc's revenue and earnings?

Precigen Inc has trailing twelve-month (TTM) revenue of $9.68M with profit margins of 0.00%. Earnings per share (EPS) is $-1.37.

Is Precigen Inc financially healthy?

Precigen Inc's Piotroski F-Score is 4/9 (moderate financial health). The Altman Z-Score of -21.62 places it in the distress.

PGEN

Precigen Inc

NASDAQ: PGEN · HEALTHCARE · BIOTECHNOLOGY

$4.16

+0.97% today

Updated 2026-04-30

Market cap

$1.46B

P/E ratio

—

P/S ratio

150.58x

EPS (TTM)

$-1.37

Dividend yield

—

52W range

$1 – $5

Volume

4.6M

Market cap

$1.46B

P/E ratio

—

P/S ratio

150.58x

EPS (TTM)

$-1.37

Dividend yield

—

52W range

$1 – $5

Volume

4.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.8

Quality

C+

2.5

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

-21.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$9.50

+128.37%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 283.60% QoQ

Risks

- Altman Z -21.62 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-24.08M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$26.91M	$6.22M	$3.92M	$9.68M	$9.68M
Net income	$28.32M	$-95.90M	$-126.23M	$-250.64M	$-23.50M
EPS	—	—	—	—	$-1.37
Free cash flow	$-69.97M	$-68.47M	$-76.76M	$-89.83M	$-24.08M
Profit margin	105.23%	-1,540.63%	-3,216.18%	-2,588.21%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PGEN	$1.46B	30	5.3	2.5	5.0	5.8	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Precigen Inc trades at $4.16. Our Smart Value Score of 30/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -21.62, it sits in the distress. TTM revenue stands at $9.68M.

Frequently asked questions

What is Precigen Inc's stock price?

Precigen Inc (PGEN) trades at $4.16.

Is Precigen Inc overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell).

What is the price target of Precigen Inc (PGEN)?

The analyst target price is $9.50, representing +128.4% upside from the current price of $4.16.

What is Precigen Inc's revenue?

TTM revenue is $9.68M.

Piotroski F-Score?

4/9 — moderate financial health.

Altman Z-Score?

-21.62 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio150.58x

ROE-572.00%

Beta1.12

50D MA$3.80

200D MA$3.72

Shares out0.35B

Float0.17B

Short ratio—

Avg volume4.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PGEN vs LLY →PGEN vs JNJ →PGEN vs ABBV →Stock screener →